About Translational research program
Bio-Repository
Bio-Repository
Bio-Repository
Collecting, processing and storing tissue and liquid biopsies to support pre-clinical research
Bio-Markers
Bio-Repository
Bio-Repository
Testing and validating biomarkers for prognosis and response to treatment
Drug Discovery
Bio-Repository
Drug Discovery
Identifying new and novel compounds targeted against NET biological abberencies
Academic Activity
Recent Presentations
Neuroendocrine Tumor Research Conference . Boston OCT 2023
Neuroendocrine tumor ex-vivo angiogenesis; correlation with overall survival and SUTENT sensitivity
Kenneth Avanzino, Joseph Mason, Mary Maluccio, Yvette Bren Mattison, J. Philip Boudreaux , Ramcharan Thiagarajan, Nicholas J. Skill
American College of Surgeons Congress, Houston, TX. Feb 2024
Stratification of neuroendocrine cancer patients for ecto-5’-nucleotidase inhibition
Michael Mauer, Nicholas Skill, Yvette Bren Mattison, and Mary Maluccio
Recent Publications
A Neuroendocrine Tumor Specialty Center in New Orleans' (NOLANETS) Response to Patient Care During the COVID-19 Pandemic. Robert A Ramirez, Yvette Bren-Mattison, Ramcharan Thiagarajan, J Philip Boudreaux, Andrew J Marsala, 1, Pamela Ryan, Mary A Maluccio. Oncologist. 2020 Jul;25(7):548-551.
Upcoming Presentations
American College of Surgeons Congress, Washington, DC. Feb 2024
Appendiceal neuroendocrine tumor (ANET) risk factors post-surgery
Joseph Mason, Kenneth Avanzino, Mary Maluccio, Yvette Bren Mattison, J. Philip Boudreaux , Ramcharan Thiagarajan, Nicholas J. Skill
American Surgical Congress, New Orleans, LA Feb 2024
Impact of positive surgical margins for neuroendocrine cancers
Sarah Jacques, Nicholas Skill, J. Philip Boudreaux, and Mary Maluccio